| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |